Delivery Order SPE2DB20D9371-SPE2DB23FT1U0

Award Date 1/19/23
Potential Completion Date 1/20/23
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,625.76 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a specialized medication used to treat opioid overdose. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,888.80 delivery order is for NARCAN 4 MG NASAL SPRAY 2S and has a completion date of September 22, 2021. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,444.40 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
This is a firm fixed-price delivery order for $2,849.04 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the drug product NARCAN 4 MG NASAL SPRAY 2S and has an ultimate completion date of August 25, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $1,018.50 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,629.60, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a specialized pharmaceutical product. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,086.40 contract is for the delivery of Narcan 4 mg nasal spray and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,403.96, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc., valued at $499,999,999 and valid through November 2026, which enables the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract award, valued at $12,222.00, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued up to $1,629.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued up to $499,999,999, that runs...
  • SPE2DB20D9371
    Indefinite Delivery Contract
  • SPE2DB20D9371-SPE2DB23FT1U0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,424.52 firm fixed-price award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a specialized prescription medication.

DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This specific delivery order falls under that broader IDC vehicle, providing the DLA direct access to DMS Pharmaceutical Group's portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award.

Generated 2/27/25, 12:38 PM